Frontiers in Oncology (Apr 2023)

Dissecting the roles and clinical potential of YY1 in the tumor microenvironment

  • MengNa Li,
  • MengNa Li,
  • MengNa Li,
  • MengNa Li,
  • JianXia Wei,
  • JianXia Wei,
  • JianXia Wei,
  • ChangNing Xue,
  • ChangNing Xue,
  • ChangNing Xue,
  • XiangTing Zhou,
  • ShiPeng Chen,
  • ShiPeng Chen,
  • ShiPeng Chen,
  • LeMei Zheng,
  • LeMei Zheng,
  • LeMei Zheng,
  • YuMei Duan,
  • YuMei Duan,
  • YuMei Duan,
  • HongYu Deng,
  • HongYu Deng,
  • HongYu Deng,
  • Wei Xiong,
  • Wei Xiong,
  • Wei Xiong,
  • FaQing Tang,
  • GuiYuan Li,
  • GuiYuan Li,
  • GuiYuan Li,
  • Ming Zhou,
  • Ming Zhou,
  • Ming Zhou,
  • Ming Zhou

DOI
https://doi.org/10.3389/fonc.2023.1122110
Journal volume & issue
Vol. 13

Abstract

Read online

Yin-Yang 1 (YY1) is a member of the GLI-Kruppel family of zinc finger proteins and plays a vital dual biological role in cancer as an oncogene or a tumor suppressor during tumorigenesis and tumor progression. The tumor microenvironment (TME) is identified as the “soil” of tumor that has a critical role in both tumor growth and metastasis. Many studies have found that YY1 is closely related to the remodeling and regulation of the TME. Herein, we reviewed the expression pattern of YY1 in tumors and summarized the function and mechanism of YY1 in regulating tumor angiogenesis, immune and metabolism. In addition, we discussed the potential value of YY1 in tumor diagnosis and treatment and provided a novel molecular strategy for the clinical diagnosis and treatment of tumors.

Keywords